Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
September 21, 2014, 12:02:32 AM

Login with username, password and session length


Members
  • Total Members: 23510
  • Latest: yuanti
Stats
  • Total Posts: 639619
  • Total Topics: 48549
  • Online Today: 159
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online
Users: 2
Guests: 156
Total: 158

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: European AIDS Conference: CD4 counts - the lower you start, the lower you finish  (Read 1399 times)

0 Members and 1 Guest are viewing this topic.

Offline BlkRedBonenla

  • Member
  • Posts: 85
    • My MySpace Page
by Gus Cairns

A study of UK patients presented at the eleventh European AIDS Conference (EACS) finds that patients starting antiretroviral (ARV) therapy gain roughly equal numbers of CD4 cells regardless of their initial count, except for those starting with extremely low or extremely high counts.

Patients starting treatment at low counts will probably never reach CD4 counts anywhere near normal. This adds to the weight of evidence that starting treatment earlier, before CD4 cell counts fall below 350 cells/mm3 or so, is better than waiting until counts have fallen below 200 cells/mm3 .

The UK CHIC cohort is a cohort of over 17,000 UK HIV patients. For the purposes of this study, patients were selected from the cohort who had started ARV therapy between the beginning of 1998 and the end of 2005 and who had maintained undetectable viral loads from six months after the start of treatment to the end of the study. They had to have had at least one pre-treatment CD4 count and another one at least six months after the start of therapy (in practice, the average number of CD4 counts done per patient was 13). They also needed annual viral load measuremenst to be included.

Over 4,100 patients met the testing criteria of which 2,780 (67.6%) maintained undetectable viral loads through to the end of 2005.

The study found that the pre-treatment (baseline) CD4 count varied according to the type of patient. For instance, gay men comprised only 38% of those starting with the lowest CD4 counts (below 25 cells/mm3), but 75% of the 91 patients starting treatment with CD4 counts over 500 cells/mm3. Conversely, heterosexuals formed 56% of those starting treatment with counts under 25 cells/mm3 but only 18% of those starting treatment with more than 500 cells/mm3. In general, a higher proportion of those starting treatment with CD4 counts below 200 cells/mm3 were female, African and heterosexual.

The cumulative CD4 increases for each stratum of baseline CD4 count are best summarised in a table: [see link below to view chart in correct format]

Baseline CD4 count -  Increase over five years
 
Under 25 -  389
 
25-50 -  322
 
50-100 -  309
 
100-200 - 285
 
200-350 - 289
 
350-500 - 281
 
Over 500  160
 


It can be seen that those with the very lowest baseline CD4 counts had the highest increases on ARVs, while those with the very highest had the lowest increases.

However there was relatively little variation in CD4 increase in those in the middle strata, with patients with 25-50 CD4 cells only gaining 40 more CD4 cells than those starting with 350-500 CD4 cells. The eventual CD4 cell count is therefore much more dependent on the baseline count than on variations in the rate of increase while on treatment, and only those starting treatment with counts above 350 cells/mm3 achieved CD4 counts nearing normality for people without HIV.

The median CD4 count at year five was 169 cells lower in those starting with 25-50 CD4 cells than in those starting with 200-350, and it was 121 higher in those starting treatment with 350-500 cells.

The rate of CD4 increase declined every year, and again there was remarkable consistency for all but those starting at the highest or lowest CD4 counts. The average CD4 count gain in the first year, in all baseline groups except those starting with more than 500 cells, was between 172 and 181 cells (those starting with over 500 gained only 98 cells).

In the second year the vast majority of patients, namely those starting at counts anywhere between 25 and 350, gained between 52 and 69 cells; in year three between 30 and 43 cells; in year four 19 to 29 cells; in year five 13 to 21 cells. CD4 cell gains in patients starting at counts below 25 were consistently higher (in the region of 12 more cells a year than any other group, apart from in the first year), and patients starting over 500 consistently lower.

There is of course huge individual variation concealed within these average figures. However the fact that the rate of CD4 increase, in all patients in this large cohort, consistently slowed down from year to year brings with it the sobering conclusion that patients who start therapy with low CD4 counts will never, at least on standard antiretroviral therapy, regain all the immune function that HIV took away.

Reference

Hughes R et al. Long-term trends in CD4 counts in patients starting HAART: UK-CHIC study. Eleventh EACS Conference, Madrid, abstract no. P14.4/04/BPD, 2007.

http://www.aidsmap.com/en/news/AEE19452-4891-4896-B231-CD6D8B6D6916.asp
- cd4 20 2/07 & 50K VL

**** 3/07 started ATRIPLA *******
- cd4 70 5/07 & Undetectable VL
- cd4 218 11/07 & Undetectable VL
-cd4 297 3/08 & Undetectable VL
-cd4 439 1/09 & Undetectable VL
-cd4 436 4/09 & Undetectable VL
-cd4 442 8/09 & Undetectable VL
-cd4 512 11/09 & Undetectable VL
-cd4 531 2/10 & Undetectable VL
-cd4 439??? 6/10 & Undetectable VL ...


_____________________________________

"A little bit of knowledge is a dangerous thing, but some minds can only handle a little." - George Bernard Shaw

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.